ORTEXORTEX News
Tracking AR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
AR
Earnings PreviewAR

AR Outperforms Peers With Lighter Short Positioning Ahead of Q3 Print

By ORTEX News · Edited by , Editor, ORTEX News2 min readdata as of 25 Oct 2026, 04:01

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Among the closest natural gas peers, AR carries one of the lighter short positions heading into Tuesday's results. Short interest in RRC and EQT runs higher on a free float basis; AR's 4.3% of float is toward the less-crowded end of the group, and it has been falling. Shorts trimmed roughly 8% over the past week and 6% over the past month, leaving 13.1 million shares short as of October 22.

The borrow market tells the same relaxed story. Availability is extremely wide at 2,334% of short interest, meaning there are more than 23 shares available to lend for every one already borrowed. Cost to borrow has drifted lower too, now at 0.45%, down 5% on the week. There is no sign of any squeeze pressure in the lending market, and availability has been expanding, not contracting, over recent weeks.

The stock's relative outperformance compounds the picture. AR added 3.9% over the past week, finishing Friday at $40.16, well ahead of a peer-group median of roughly 1.3%. RRC led the group at +5.3%, but EXE slipped 0.2% and DEC fell nearly 1%. AR also gained 17% over the past month, a move that has attracted attention: Wikipedia traffic and ORTEX page views are running more than two standard deviations above the company's own 90-day baseline, a level of retail interest that typically accompanies price momentum rather than precedes it.

Analyst sentiment has been active in the run-up. Morgan Stanley raised its target to $51 from $49 last week while keeping its Overweight rating, a mild upgrade signal from a bellwether firm. Scotiabank initiated at Sector Outperform with a $46 target on the same day. The direction of travel from other desks has been softer: Mizuho, UBS, Truist and Jefferies all trimmed targets in early October, though each maintained a Buy or Outperform rating. The consensus mean sits at $49.64, implying roughly 24% upside from the current price. Valuation has re-rated alongside the share price, with the price-to-book multiple expanding by 11% over the past month to 1.26x, though the stock remains modestly priced on earnings at a PE of 8.7x.

The print on October 28 will test whether the Q3 operating result justifies a share price that has moved sharply higher even as several sell-side desks pulled back their targets, and whether production efficiency and gas realisation figures are strong enough to sustain the premium AR has quietly built over its peer group this month.

Stocks in this article

See the live data behind this article on ORTEX.

Open AR on ORTEX →

How this article was generated

Generated
25 Oct 2026, 04:18
Data as of
25 Oct 2026, 04:01
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.